Equinix (EQIX)
NASDAQReal EstateReit - SpecialtySnapshot 2026-07-07
$1022.93+2.41%
Close 2026-07-07 · 1-day change
Reading EQIX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EQIX free→NASDAQReal EstateReit - SpecialtySnapshot 2026-07-07
Reading EQIX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EQIX free→QuarterlyIQ Insights · EQIX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 9 valuation methods, at three horizons. Current price $1022.93. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $1,023 EQIX trades at 28× p/ffo — 1.8× the 16× p/ffo peer median. The market is re-rating it beyond its own range; our $792 fair value is low-confidence here. Analysts target $1,109–$1,250. Note: our $792 fair value sits below the entire analyst range ($1,109–$1,250). Not investment advice.
$1109.00 – $1250.00 (median $1200.00) · 11 analysts · as of 2026-07-01
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $1200.00 | — | — | Analyst | high |
| ddm gordon | 12M | $351.61 | — | — | TTM | high |
| graham number | 12M | $222.68 | — | — | TTM | high |
| Peer P/FFO | 12M | $582.29 | 16.2 | 35.99 | TTM | high |
| Peer P/S | 12M | $758.58 | 7.9 | 95.58 | TTM | high |
| PEG | 12M | $450.47 | 29.6 | 15.22 | TTM | high |
| residual income | 12M | $158.51 | — | — | TTM | high |
| Own P/E history | 12M | $1092.19 | 71.8 | 15.22 | TTM | high |
| triangulated | 12M | $261.85 | 16.2 | 16.18 | Triangulated | high |
| Peer P/FFO | 3Y | $803.61 | 16.2 | 49.67 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $1023.69 | 7.9 | 128.98 | guidance | medium |
| PEG | 3Y | $643.00 | 29.6 | 21.73 | Analyst | medium |
| Own P/E history | 3Y | $1558.99 | 71.8 | 21.73 | Analyst | medium |
| Peer P/FFO | 5Y | $996.13 | 16.2 | 61.57 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $1194.76 | 7.9 | 150.53 | guidance | high |
| PEG | 5Y | $750.45 | 29.6 | 25.36 | Analyst | high |
| Own P/E history | 5Y | $1819.52 | 71.8 | 25.36 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.